VIVA Biotech Holdings
HKEX:1873
Cash Flow Statement
Cash Flow Statement
VIVA Biotech Holdings
Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||
Net Income |
(356)
|
288
|
348
|
162
|
(459)
|
(359)
|
|
Depreciation & Amortization |
70
|
122
|
153
|
172
|
185
|
204
|
|
Other Non-Cash Items |
409
|
(135)
|
(116)
|
65
|
758
|
681
|
|
Cash Taxes Paid |
17
|
27
|
45
|
71
|
81
|
100
|
|
Cash Interest Paid |
12
|
52
|
71
|
66
|
73
|
73
|
|
Change in Working Capital |
(91)
|
(246)
|
(307)
|
(247)
|
(98)
|
86
|
|
Cash from Operating Activities |
32
N/A
|
29
-9%
|
78
+165%
|
152
+96%
|
386
+153%
|
611
+58%
|
|
Investing Cash Flow | |||||||
Capital Expenditures |
(593)
|
(764)
|
(565)
|
(481)
|
(250)
|
(215)
|
|
Other Items |
(3 246)
|
(3 274)
|
(304)
|
284
|
(123)
|
(70)
|
|
Cash from Investing Activities |
(3 838)
N/A
|
(4 038)
-5%
|
(869)
+78%
|
(197)
+77%
|
(373)
-89%
|
(284)
+24%
|
|
Financing Cash Flow | |||||||
Net Issuance of Common Stock |
918
|
836
|
(128)
|
(64)
|
0
|
0
|
|
Net Issuance of Debt |
4 458
|
2 572
|
(425)
|
252
|
(73)
|
85
|
|
Cash Paid for Dividends |
(52)
|
0
|
(16)
|
0
|
0
|
0
|
|
Other |
(17)
|
(66)
|
(84)
|
(65)
|
(71)
|
(71)
|
|
Cash from Financing Activities |
5 307
N/A
|
3 291
-38%
|
(653)
N/A
|
106
N/A
|
(143)
N/A
|
14
N/A
|
|
Change in Cash | |||||||
Effect of Foreign Exchange Rates |
(97)
|
(134)
|
(63)
|
(18)
|
8
|
21
|
|
Net Change in Cash |
1 404
N/A
|
(852)
N/A
|
(1 508)
-77%
|
43
N/A
|
(122)
N/A
|
361
N/A
|
|
Free Cash Flow | |||||||
Free Cash Flow |
(560)
N/A
|
(735)
-31%
|
(487)
+34%
|
(329)
+32%
|
137
N/A
|
396
+190%
|